Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
beLP3
- Development stage
- Preclinical
- Lead developer
- Bereum
- Modality
- Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
beLP3 is a multi-strain postbiotic ingredient developed by Bereum, consisting of a heat-treated (tyndallized) combination of three Lactobacillus strains: *Lactobacillus plantarum*, *Lactobacillus casei*, and *Lactobacillus acidophilus*. As a postbiotic, it contains inanimate microbial cells and their components that confer health benefits on the host. This specific formulation is designed to be highly stable under various processing conditions, including high heat and acidic environments, making it suitable for use in dietary supplements and functional foods. The combination of these three strains is intended to provide synergistic effects for immune system modulation and the maintenance of intestinal health.
- Brand names
- beLP3beLP-3beLP 3
- Other names
- 3-strain Postbioticheat-treated Lactobacillus plantarum + Lactobacillus casei + Lactobacillus acidophilus
Beyond the preview
Go deeper on beLP3.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on beLP3.